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Abstract. Regional blood distribution was studied in rats, which were divided into
four groups viz., (i) control, (ii) exposed to acute hypobaric hypoxia, (iii) exposed
to acute hypobaric hypoxia after oral treatment with 25 mg acetazolamide, and (iv)
exposed to acute hypobaric hypoxia after oral treatment with 6 mg spironolactone.
The regional blood distribution was measured using radio-iodinated serum albumin
(R131ISA). The acute hypoxic exposure results in major readjustment in the blood
flow to the various organs mainly from the renal and splanchic vascular beds to the
heart and brain. Treatment with acetazolamide and spironolactone results only in a
slight decrease in blood contents of the heart, brain and lung as compared to the
hypoxia alone exposed group.
1. Introduction
It is well known that high altitude induces an increase in blood flow so that the
oxygen delivery to tissues is maintained1'2. However^ such a situation may not exist
throughout all vascular beds. A potential mechanism for such increased blood flow
would be setting of a balance, within each organ or tissue, between central autonomic
produced vasoconstriction on the one hand and autonomic, metabolic and circulatory
agent produced vasodilation on the other. Very limited work on regional blood distri-
bution under acute hypoxic exposure, has been reported in the literature3'1, however
their findings are inconsistent. Certain drugs have been tried on experimental basis to
ameliorate some of the symptoms of acute mountain sickness (AMS). Aceta-
zolamide8'6 and spironolactone7'8 have been reported to be of some help in ameliorat-
ing the symptoms of AMS at very high altitude, but their exact mode of action is
not well understood. Possibly, both these drugs affect the blood flow to the various
organs and hence the oxygen delivery to them. The purpose of the present work is to
investigate the regional blood distribution in various organs and tissues of rats on
exposure to hypobaric hypoxia, and to see the effect of acetazolamide and spironol-
actone on the regional blood distribution.
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2. Materials and Methods
Studies have been carried out in 48 male albino rats weighing 200-250 g divided into
four groups of 12 each, namely (1) control, (2) exposed to acute hypobaric hypoxia,
(3) oral administration of 25 mg acetazolamide with hypobaric hypoxia, and (4)
oral administration of 6 mg spironolactone with hypobaric hypoxia. The hypoxic
exposure was given in a hypobaric chamber maintained at 350 torr corresponding to
an altitude of 6,100 m at ambient room temperature for five hours.
The animals were anesthized by an intraperitoneal injection of (35 mg/kg body wt)
sodiutn pentabarbitoL The regional blood distribution was measured using radio-iodi-
nated serum albumin-131 (R131ISA). The radio-active material was diluted with 0.9
per cent sterile saline solution, and from the stock solution 0.2 ml of solution con-
taining 1 jitCi of RISA-131 was injected through the left femoral vein. The drug was
given orally to the rats in group (3) & (4), before starting the exposure. One minute
after the injection, about 1.5 ml blood was drawn by cardiac puncture. Maximum
amount of blood was drawn out by cutting the dorsal aorta. The lung, liver, heart,
spleen, right thigh muscle, right kidney, right testes and subcutaneous tissue from the
abdomen were excised, and superficial facia and fat were removed. The organ and
tissues were gently blotted with filter paper and the wet weight was recorded. The
brain was removed after cutting across the frontal, parietal and interparietal bones
and weighed immediately. All the organs and tissues were counted in a gamma-ray
spectrometer and these counts were compared wtih counts of 1.0 ml of blood hemolysed
with a pint of saponin to give the blood contents of the organ.
3. Results
Table 1 summarised the blood contents expressed in p\ per gram of wet organ weight
in the various organs, namely, lung, liver, heart, subcutaneous tissue, brain, spleen,
diaphragm, right thigh muscle, right testes and right kidney in all the four groups of
rats : (1) control (2) exposed to acute hypoxia (3) exposed to hypoxia after treatment
with acetazolamide and (4) exposed to hypoxia after treatment with spironolactone.
On hypoxic exposures splanchic blood flow, as shown by the blood contents of
liver and spleen, is decreased by 25.1 per cent (P<0.05) and 10.4 per cent respectively.
The blood contents of the lung decreased by 10.3 per cent while that of the heart
increased by 32.2 per cent (P<0.01). Regional blood flow as shown by blood contents
of kidney, decreased by 16.7 per cent (P<0.05). There had been a reduction in blood
content by 13.8 per cent in the subcutaneous tissue (P<0.001), Cerebral blood flow
increased by 16.4 per cent (P<0.05) as shown by the blood content of the brain. There
was no change in the blood content of thigh muscle and testes.
Treatment with both the drugs namely acetazolamide and spironolactone, resulted
in further marginal decrease in the blood content of the lungs, liver and subcutaneous
tissue. The blood contents of the heart increased to a less extent in both the drug
treated groups as compared to the hypoxia exposed group. Treatment with acetazo-
lamide resulted in further elevation in blood content of the brain, as compared to
hypoxia exposed group, while no change was found in spironolactone treated rats.
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Table 1. Regional blood contents in rats on acute altitude exposure with or without
acetazolamide and Spironolactone treatment.
Organ Control Hypoxia Hypoxia c
acetazolamide
*P<0.05 **P<0.001
Hypoxic c
Spironolactone
Lung
Liver
Heart
Brain
Subcuta-
neous tissue
Spleen
Thigh
muscle
Testes
Kidney
328.7
±21.3
279.4
±27.8
214.9
±14.9
25.6
±1.0
257.0
±2.7
160.0
±11.3
17.3
±1.0
30.2
±4.0
263.7
±14.3
294.9
±12.7
209.2*
±10.2
284.1*
±16.4
29.8*
±1.5
221.6**
±3.1
143.3
±6.0
19.5
±4.3
28.3
±4.0
219.8*
±11.5
286.8
±16.5
201.3*
±18.6
271.9*
±15.8
31.7*
±1.5
219.6**
±3.2
139.9
±8.4
20.4
±3.3
30.1
±3.9
259.5
±13.1
284.7
±17.2
203.2*
±16.4*
268.5*
±17.7
29.9*
±1.7
218.9**
±3.4
141.2
±9.2
23.6
±3.5
31.2
±4.7
268.7
±15.3
The blood content of the kidney returned to control levels in both the drug treated
rats. No significant change was found in blood contents of the spleen, thigh muscle
and testes, on treatment with drugs as compared to hypoxia exposed group.
4. Discussion
Many workers have reported that moderate hypoxia results in an increased cardiac
output3'9-11- Korner11 reported that very severe hypoxia will reverse this response in
the rabbit. Vogel et a/4 confirmed the enhancement of total blood flow together with
a major readjustment of the proportion of the increased cardiac output to various
tissues.
We have found a significant decrease in blood content in liver, kidney and sub-
cutaneous tissue in the rats indicating vasoconstriction in these organs on hypoxic
exposure. The lung, spleen and testes showed an insignificant decrease in their blood
contents. In contrast, the heart and skeletal muscle showed significantly increased
blood contents, indicating a net vasodilation in these tissues.
Our results indicated a reduction in renal blood content on hypoxic exposure and
confirmed the findings as observed in anaesthetized dogs and rabbits4'12-14. Axelrod
and Pitts15, McDonald and Kelley16, Caldwell et al." and Berger et a/18 found renal
flow to be unaffected by hypoxia. Severe hypoxia is reported to result in considerable
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renal vasoconstriction and a corresponding decrease in blood flow19. Significant
reduction in hepatic blood flow was reported by Chalmers et al10 and Vogel et al*,
while Fischer et al20 found a variable response in hepatic blood flow in the anaesthe-
tized dogs subjected to moderate hypoxia. However, significant reduction in hepatic
blood flow was reported by Chalmers et al10 and Vogel et al\ which is in agreement
with our findings.
We have found an increased skeletal blood content in rats on acute hypoxic
exposure. Vogel et al* and Black and Roddie21 also reported large increases in blood
flow to skeletal muscle during hypoxia. Kety and Schmidt22 observed substantial in-
crease in cerebral blood flow during brief bypoxic exposure. Kirk23 found no change
in lung blood content on hypoxic exposure using indicator dilution method, inspite
of increased pulmonary arterial pressure.
The present decrease in blood content of the lungs may be attributed to a differen-
tial loss of blood on cutting of dorsal aorta because of increased pulmonary arterial
pressure. *
The treatment of rats with either acetazolamide or spironolactone resulted in a
marginal decrease in blood contents of the lung, liver, heart, subcutaneous tissue and
spleen compared to rats exposed to hypoxia alone as both these drugs are mild
diuretics. Gray et al? reported acetazolamide to be effective in ameliorating some of
the AMS symptoms due to increased H+ ion concentration in the cerebrospinal
fluid which influences cerebral blood flow and results in a greater degree of hyper-
ventilation, resulting in higher pO2 and lower pCO2. Laux and Raichle6 found that
acetazolamide produces an immediate and significant increase in cerebral blood flow,
which partially compensated reduced tissue oxygen availability. We have also observed
a slight increase in blood contents of the brain. However, no change occurs in blood
content of brain on treatment with spironolactone. Both these drugs resulted in
restoring the normal blood contents of the kidney due to their diuretic action. The
decreased blood content of the lungs may be helpful in ameliorating pulmonary
edema.
In conclusion, the cardiovascular response to acute hypoxic exposure results in
the major readjustment of the blood flow to the various tissues. The blood from renal
and splanchic vascular beds was diverted to the heart and brain.
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